S
ABBV icon

Sunpointe’s AbbVie ABBV Stock Holding History

Sunpointe’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$804K Sell
3,697
-84
-2% -$18.6K 0.26% 88
2025
Q4 		$864K Sell
3,781
-188
-5% -$42.8K 0.29% 71
2025
Q3 		$919K Sell
3,969
-77
-2% -$15.7K 0.33% 65
2025
Q2 		$751K Buy
4,046
+187
+5% +$34.8K 0.3% 77
2025
Q1 		$809K Sell
3,859
-542
-12% -$105K 0.43% 49
2024
Q4 		$782K Buy
4,401
+1,013
+30% +$186K 0.39% 54
2024
Q3 		$669K Buy
3,388
+441
+15% +$82.3K 0.55% 47
2024
Q2 		$505K Sell
2,947
-192
-6% -$31.8K 0.33% 62
2024
Q1 		$572K Sell
3,139
-628
-17% -$108K 0.64% 41
2023
Q4 		$584K Buy
+3,767
New +$549K 0.74% 34

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sunpointe's ABBV Position: Q1 2026 in Review

Sunpointe reduced its AbbVie (ABBV) stake by 2.2% in Q1 2026, selling an estimated $18.6K and leaving 3,697 shares worth $804K. The position accounts for 0.26% of the portfolio, ranked #88.

Sunpointe first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $919K in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Sunpointe held 3,697 shares of AbbVie worth $804K as of Q1 2026.
  • Sunpointe sold 84 AbbVie shares in Q1 2026, an estimated $18.6K.
  • AbbVie made up 0.26% of Sunpointe's portfolio in Q1 2026, its #88 holding.
  • Sunpointe first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
  • Sunpointe's AbbVie position peaked at $919K in Q3 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Sunpointe's 13F filing for Q1 2026, filed 21 Apr 2026.